Search results for: 'android ed pacif terminal forecast 2026'

The global pharmaceutical market is projected to reach approximately $1.72 trillion in 2026, with large molecules driving most incremental growth while small molecules remain the sector’s cash flow base. The current growth cycle concentrates on cardiometabolic and oncology, led by GLP-1 platforms and antibody–drug conjugates (ADCs). Competitive adv...

The Healthcare IT Outlook 2026 examines the industry’s transition from experimentation to enterprise-scale execution, as artificial intelligence (AI), workflow orchestration, and platform consolidation reshape clinical, operational, and financial workflows. Following several years of pilot-led innovation, 2026 marks a pivotal inflection point where...

In the rapidly evolving landscape of 2026, where technological advancements are accelerating, the ability to identify, invest in, and leverage these advancements is becoming increasingly critical for organizations aiming to maintain industry leadership and ensure sustainable growth. Recognizing this imperative, Frost & Sullivan introduces (launches...

HIMSS 2026, held in Las Vegas, brought together 24,000+ stakeholders and 900+ exhibitors, underscoring the growing urgency for healthcare organizations to translate digital investments into measurable outcomes amid cost pressures, workforce shortages, and rising care complexity. Discussions at the event highlighted a clear shift from innovation-led...

This Frost & Sullivan annual outlook analyzes the medical devices industry across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa. The study provides insights into market size, growth rates, opportunities, strategic imperatives, and macroeconomic trends shaping the medical devices industry. The study period spans 202...

The European Congress of Radiology (ECR) 2026 in Vienna highlighted the transformative role of artificial intelligence (AI) in imaging, advances in personalized medicine, and sustainability in healthcare. The theme “Rays of Knowledge” emphasized education, innovation, and collaboration across disciplines, with a record-high attendance and over 11,0...

ViVE 2026, held February 22–25 in Los Angeles, brought together more than 7,000 attendees, 230+ speakers, and 300 exhibitors to define the year’s direction in digital health. It reinforced a pivotal message for the healthcare IT ecosystem: AI has moved beyond experimentation and is now a core enterprise capability requiring scale, governance, and a...

The global clinical diagnostics market is poised for strong growth, driven by increased adoption of advanced diagnostics technologies, greater investment in laboratories, and improved access to molecular and immunodiagnostic testing facilities. In 2025, the industry continued its transformation, establishing testing systems as intelligent systems...

The global biopharma patient access market is undergoing a structural shift as specialty medicines make downstream commercialization more complex and strategically important. Patient access is no longer limited to reimbursement support or hub services; it is becoming a commercialization control layer spanning authorization, affordability, therapy i...